Regulatory Specialist
HeartFlowSalary not specified
- Full Time
- Junior (1 to 2 years)
About HeartFlow
HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.
Redwood City, CaliforniaHeadquarters
2010Year Founded
$858.5MTotal Funding
SERIES_FCompany Stage
HealthcareIndustries
501-1,000Employees
Benefits
Remote Work Options
Stock Options
401(k) Company Match
Risks
Emerging AI-driven competitors could threaten HeartFlow's market share.
Algorithmic bias in AI models could lead to inaccurate diagnoses.
Integration into healthcare systems may face resistance due to complexity and cost.
Differentiation
HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.
HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.
HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.
Upsides
HeartFlow closed a $215 million Series F funding round in April 2023.
The global non-invasive cardiac imaging market is projected to grow significantly.
HeartFlow's technology aligns with the trend towards value-based care in healthcare.
Funding
Total raised$858.52 M
Latest valuation$1.50 B
StageSERIES_F
LATE VC
5/31/2019$65
$325.00 MSERIES E
1/31/2018$240
$1.50 BSERIES D
4/30/2016$100
$499.50 MSERIES C
1/31/2014$105
$523.50 MSERIES B
1/31/2011$20
$102.00 MDEBT
5/31/2010$10
SERIES A
3/31/2010$2
$8.00 MSEED
6/30/2009N/A
$975.0 K